1.Clinical features of CAPOS syndrome caused by maternal ATP1A3 gene variation: a case report.
Yun GAO ; Fengjiao LI ; Rong LUO ; Guohui CHEN ; Danyang LI ; Dayong WANG ; Qiuju WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2024;38(1):73-76
CAPOS syndrome is an autosomal dominant neurological disorder caused by mutations in the ATP1A3 gene. Initial symptoms, often fever-induced, include recurrent acute ataxic encephalopathy in childhood, featuring cerebellar ataxia, optic atrophy, areflflexia, sensorineural hearing loss, and in some cases, pes cavus. This report details a case of CAPOS syndrome resulting from a maternal ATP1A3 gene mutation. Both the child and her mother exhibited symptoms post-febrile induction,including severe sensorineural hearing loss in both ears, ataxia, areflexia, and decreased vision. Additionally, the patient's mother presented with pes cavus. Genetic testing revealed a c. 2452G>A(Glu818Lys) heterozygous mutation in theATP1A3 gene in the patient . This article aims to enhance clinicians' understanding of CAPOS syndrome, emphasizing the case's clinical characteristics, diagnostic process, treatment, and its correlation with genotypeic findings.
Humans
;
Child
;
Female
;
Cerebellar Ataxia/diagnosis*
;
Talipes Cavus
;
Hearing Loss, Sensorineural/diagnosis*
;
Optic Atrophy/diagnosis*
;
Mutation
;
Phenotype
;
Sodium-Potassium-Exchanging ATPase/genetics*
;
Foot Deformities, Congenital
;
Reflex, Abnormal
2.Analysis of clinical features and ATRX gene variants in a Chinese pedigree affected with X-linked alpha thalassemia mental retardation (ATR-X) syndrome.
Rui DONG ; Yali YANG ; Hui GUO ; Min GAO ; Yuqiang LYU ; Yue LI ; Xiaomeng YANG ; Yi LIU
Chinese Journal of Medical Genetics 2023;40(12):1508-1511
OBJECTIVE:
To explore the clinical characteristics and genetic basis of two brothers featuring X-linked alpha thalassemia mental retardation (ATR-X) syndrome.
METHODS:
An infant who had presented at the Qilu Children's Hospital in 2020 for unstable upright head and inability to roll over and his family were selected as the study subjects. The clinical features of the child and one of his brothers were summarized, and their genomic DNA was subjected to targeted capture and next generation sequencing (NGS).
RESULTS:
The brothers had presented with mental retardation and facial dysmorphisms. NGS revealed that they had both harbored a hemizygous c.5275C>A variant of the ATRX gene located on the X chromosome, which was inherited from their mother.
CONCLUSION
The siblings were diagnosed with ATR-X syndrome. The discovery of the c.5275C>A variant has enriched the mutational spectrum of the ATRX gene.
Humans
;
Infant
;
Male
;
alpha-Thalassemia/diagnosis*
;
Ataxia Telangiectasia Mutated Proteins/genetics*
;
East Asian People
;
Intellectual Disability/genetics*
;
Mental Retardation, X-Linked/diagnosis*
;
Pedigree
;
X-linked Nuclear Protein/genetics*
3.Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia
Prashant SINGH ; Yoonjin SEO ; Sarah BALLOU ; Andrew LUDWIG ; William HIRSCH ; Vikram RANGAN ; Johanna ITURRINO ; Anthony LEMBO ; Judy W NEE
Journal of Neurogastroenterology and Motility 2019;25(1):129-136
BACKGROUND/AIMS: Although symptoms related to the pelvic floor, such as pelvic organ prolapse (POP) and lower urinary tract symptoms (LUTS), are common in patients with chronic constipation (CC), its impact is not clear. Our aims were to investigate the following (1) compare pelvic floor symptom related dysfunction in irritable bowel syndrome with constipation (IBS-C) and functional constipation (FC), and (2) symptom correlation with findings on anorectal manometry (ARM) and balloon expulsion test. METHODS: This was a retrospective analysis of patients with CC undergoing ARM. IBS-C and FC were diagnosed by Rome III criteria. Pelvic Floor Distress Inventory (PFDI-20) was used to measure pelvic floor symptom distress. Constipation Severity Scale was used to assess constipation severity. RESULTS: A total of 107 patients underwent ARM (64 FC, 43 IBS-C). The overall PFDI-20 score in IBS-C was higher compared with FC patients (118.0 vs 79.2, P = 0.001). In those with IBS-C, POP, LUTS, and colorectal symptoms subscales were all higher compared with FC patients (P < 0.05 for each). On multivariable regression, IBS-C (P = 0.001) and higher constipation severity (P = 0.001) were both independently associated with higher PFDI scores. ARM parameters and abnormal balloon expulsion test did not correlate with PFDI scores. CONCLUSIONS: Compared with FC patients, those with IBS-C have significantly higher distress from pelvic floor specific symptoms including POP and LUTS. Higher abdominal pain among IBS-C patients did not entirely explain these findings. A diagnosis of IBS-C and higher constipation severity correlated with PFDI-20 scores, but dyssynergia did not.
Abdominal Pain
;
Arm
;
Ataxia
;
Constipation
;
Defecation
;
Diagnosis
;
Humans
;
Irritable Bowel Syndrome
;
Lower Urinary Tract Symptoms
;
Manometry
;
Pelvic Floor
;
Pelvic Organ Prolapse
;
Retrospective Studies
4.Diagnostic Challenges Associated with GLUT1 Deficiency: Phenotypic Variabilities and Evolving Clinical Features
Hyuna KIM ; Jin Sook LEE ; Youngha LEE ; Soo Yeon KIM ; Byung Chan LIM ; Ki Joong KIM ; Murim CHOI ; Jong Hee CHAE
Yonsei Medical Journal 2019;60(12):1209-1215
GLUT1 deficiency is a rare neurometabolic disorder that can be effectively treated with ketogenic diet. However, this condition is underdiagnosed due to its nonspecific, overlapping, and evolving symptoms with age. We retrospectively reviewed the clinical course of nine patients diagnosed with GLUT1 deficiency, based on SLC2A1 mutations and/or glucose concentration in cerebrospinal fluid. The patients included eight boys and one girl who initially presented with seizures (44%, 4/9) or delayed development (44%, 4/9) before 2 years of age, except for one patient who presented with apnea as a neonate. Over the clinical course, all of the children developed seizures of the mixed type, including absence seizures and generalized tonic–clonic seizures. About half (56%, 5/9) showed movement disorders such as ataxia, dystonia, or dyskinesia. We observed an evolution of phenotype over time, although this was not uniform across all patients. Only one child had microcephaly. In five patients, ketogenic diet was effective in reducing seizures and movement symptoms, and the patients exhibited subjective improvement in cognitive function. Diagnosing GLUT1 deficiency can be challenging due to the phenotypic variability and evolution. A high index of clinical suspicion in pediatric and even older patients with epilepsy or movement disorders is key to the early diagnosis and treatment, which can improve the patient's quality of life.
Apnea
;
Ataxia
;
Cerebrospinal Fluid
;
Child
;
Clothing
;
Cognition
;
Dyskinesias
;
Dystonia
;
Early Diagnosis
;
Epilepsy
;
Epilepsy, Absence
;
Female
;
Glucose
;
Humans
;
Infant, Newborn
;
Ketogenic Diet
;
Microcephaly
;
Movement Disorders
;
Phenotype
;
Quality of Life
;
Retrospective Studies
;
Seizures
5.Niemann-Pick Disease Type C Misdiagnosed as Cerebral Palsy: A Case Report
Eun Jae KO ; In Young SUNG ; Han Wook YOO
Annals of Rehabilitation Medicine 2019;43(5):621-624
Niemann-Pick disease type C (NP-C) is a rare autosomal recessive neurovisceral lysosomal lipid storage disorder. The clinical manifestations of the disorder are variable. This report describes the case of a 27-month-old girl with NP-C whose condition had been misdiagnosed as spastic cerebral palsy (CP). She had spasticity, particularly at both ankles, and gait disturbance. Magnetic resonance imaging of the brain revealed findings suspicious of sequelae from a previous insult, such as periventricular leukomalacia, leading to the diagnosis of CP. However, she had a history of hepatosplenomegaly when she was a fetus and her motor development had deteriorated, with symptoms of vertical supranuclear gaze palsy, cataplexy, and ataxia developing gradually. Therefore, NP-C was considered and confirmed with a genetic study, which showed mutation of the NPC1 gene. Thus, if a child with CP-like symptoms presents with a deteriorating course and NP-C-specific symptoms, NP-C should be cautiously considered.
Ankle
;
Ataxia
;
Brain
;
Cataplexy
;
Cerebral Palsy
;
Child
;
Child, Preschool
;
Diagnosis
;
Female
;
Fetus
;
Gait
;
Humans
;
Infant, Newborn
;
Leukomalacia, Periventricular
;
Magnetic Resonance Imaging
;
Muscle Spasticity
;
Niemann-Pick Diseases
;
Paralysis
6.Dysphagia as a Clinical Manifestation of Monoclonal Gammopathy of Undetermined Significance: A Case Report
Hyunjung KOO ; Geun Young PARK ; Yeonjae HAN ; Sangah JEONG ; Sun IM
Journal of the Korean Dysphagia Society 2019;9(2):93-98
Swallowing can be affected by a variety of systemic diseases. The etiology of dysphagia in the geriatric population is usually overlooked due mainly to a presumed diagnosis of presbyphagia or difficulty in revealing the direct cause. On the other hand, dysphagia can be a meaningful clinical sign of premalignant systemic disease. A 78-year-old man, without any prior medical or family history, was admitted with the chief complaint of dysphagia with recent aspiration pneumonia. Instrumental swallowing tests revealed a severe degree of dysphagia due to decreased laryngopharyngeal sensation and weakness of the pharyngeal constrictor muscles. Extensive workup, including electromyography and laboratory tests, revealed severe sensorimotor peripheral polyneuropathy related to monoclonal gammopathy. Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant precursor of multiple myeloma, which is characterized by the proliferation of monoclonal proteins. These conditions are often associated with peripheral polyneuropathy, ataxia, and sometimes even muscle weakness. Although dysphagia can occur in other systemic disorders, such as vasculitis or paraneoplastic syndrome-related malignancies, there are few reports of dysphagia related to MGUS. The patient was followed up for three years. The MGUS showed no further progression, but the patient showed no improvement, indicating a protracted clinical course and poor prognosis when dysphagia is related to MGUS.
Aged
;
Ataxia
;
Deglutition
;
Deglutition Disorders
;
Diagnosis
;
Electromyography
;
Hand
;
Humans
;
Monoclonal Gammopathy of Undetermined Significance
;
Multiple Myeloma
;
Muscle Weakness
;
Muscles
;
Paraproteinemias
;
Pneumonia, Aspiration
;
Polyneuropathies
;
Prognosis
;
Sensation
;
Vasculitis
7.A Case of Acute Hemorrhagic Encephalomyelitis associated with Mycoplasma Pneumoniae Infection.
Yunha CHOI ; Jeongho LEE ; Eun Sook SUH
Journal of the Korean Child Neurology Society 2018;26(1):70-73
Acute hemorrhagic encephalomyelitis (AHEM) is a severe form of encephalitis characterized by fulminant clinical course and presence of hemorrhagic necrosis of the white matter. Mycoplasma pneumoniae (M. pneumoniae) have severe central nervous syndrome complication with encephalitis as that most common pediatric manifestations, but have been extremely rare report with AHME. A 10-year-old boy was referred to emergency room because of drowsy mental status, weakness of left side extremities and truncal ataxia. His deep tendon reflexes were hyperactive, neck stiffness sign and Babinski sign were both positive. Motor power were decreased on the both left upper and lower extremities. The sequences of T2-weighted and gradient recalled echo (GRE) showed hyper-intense lesions on multifocal white natter areas with hemorrhagic signal. Cerebrospinal fluid (CSF) analysis showed the pleocytosis with neutrophil dominant. The results of deoxyribonucleic acid (DNA) test and culture of M. pneumoniae were reported negative in CSF, but immunoglobulin M (IgM) was positive in blood. He received intravenous high dose corticosteroid and macrolide. After discharge, his neurologic function gradually returned to normal including sitting and standing without support. We reported the previously healthy boy with M. pneumonia related AHEM. The early diagnosis with brain MRI and the aggressive immunosuppressive treatment may be beneficial for recovery.
Ataxia
;
Brain
;
Cerebrospinal Fluid
;
Child
;
DNA
;
Early Diagnosis
;
Emergency Service, Hospital
;
Encephalitis
;
Extremities
;
Humans
;
Immunoglobulin M
;
Leukocytosis
;
Leukoencephalitis, Acute Hemorrhagic*
;
Lower Extremity
;
Magnetic Resonance Imaging
;
Male
;
Mycoplasma pneumoniae*
;
Mycoplasma*
;
Neck
;
Necrosis
;
Neutrophils
;
Pneumonia
;
Pneumonia, Mycoplasma*
;
Reflex, Babinski
;
Reflex, Stretch
;
White Matter
8.Brain metastasis from colorectal cancer: a single center experience
Dong Yeop KIM ; Chun Geun RYU ; Eun Joo JUNG ; Jin Hee PAIK ; Dae Yong HWANG
Annals of Surgical Treatment and Research 2018;94(1):13-18
PURPOSE: The detection rate of brain metastasis (BM) from colorectal cancer (CRC) is increasing. This study was designed to analyze the clinical features of BM and prognosis according to the therapeutic modalities. METHODS: A total of 19 cases were collected in this study between November 2008 and December 2015. We reviewed the patients' demographic data and the clinical features of BM retrospectively and investigated their prognostic significance. RESULTS: Nineteen patients included 8 male and 11 female patients. The median age at diagnosis of BM was 62.4 years (range, 32–83 years). The median interval between diagnosis of CRC and BM was 39 months (range, 0–98 months). Eighteen patients (94.7%) had extracranial metastasis at the diagnosis of BM. Lung was the most common site of extracranial metastasis in 14 patients (73.7%). Synchronous BMs were found at the diagnosis of primary CRC in 2 patients (10.5%). The location of primary CRC was the colon in 6 patients (31.6%) and the rectum in 13 patients (68.4%). At the diagnosis of BM, 10 patients (52.6%) had a solitary BM. The common neurologic symptoms were headache in 8 cases (42.1%) and ataxia in 6 cases (31.6%). The median survival after the diagnosis of BM was 3 months (range, 1–10 months). The patients who underwent surgery plus stereotactic radiosurgery (SRS) had an improved survival (range, 3–10 months) than the other patients (range, 1–6 months) (P = 0.016). CONCLUSION: In patients with BM from CRC, surgical resection plus SRS might improve survival.
Ataxia
;
Brain
;
Colon
;
Colorectal Neoplasms
;
Diagnosis
;
Female
;
Headache
;
Humans
;
Lung
;
Male
;
Neoplasm Metastasis
;
Neurologic Manifestations
;
Prognosis
;
Radiosurgery
;
Rectum
;
Retrospective Studies
9.Sleep Related Problems as a Nonmotor Symptom of Dentatorubropallidoluysian Atrophy.
Hyeyun KIM ; Ji Young YUN ; Kyoung Gyu CHOI ; Heasoo KOO ; Hyun Jeong HAN
Journal of Korean Medical Science 2018;33(17):e130-
Dentatorubropallidoluysian atrophy (DRPLA) is a neurodegenerative disease caused by an expansion of a cytosine-adenine-guanine (CAG) repeat encoding a polyglutamine tract in the atrophin-1 protein. Unlike other CAG repeat diseases, sleep related problems have not been reported in patients with DRPLA. There was a 65-year-old man and his family with DRPLA. They suffered from seizure, gait disturbance, and cognitive decline. The patients commonly showed dream enacting sleep disorder, insomnia. The results from overnight polysomnography showed rapid eye movement (REM) without atonia in patients with DRPLA. The man died 2 years after diagnosis and was subjected for brain autopsy. We report REM sleep behavior disorders in patients with DRPLA confirmed with polysomnography with pathological description of the patient.
Aged
;
Atrophy*
;
Autopsy
;
Brain
;
Cerebellar Ataxia
;
Diagnosis
;
Dreams
;
Gait
;
Humans
;
Mental Disorders
;
Neurodegenerative Diseases
;
Polysomnography
;
Seizures
;
Sleep Initiation and Maintenance Disorders
;
Sleep Wake Disorders
;
Sleep, REM
10.The Etiologies of Chronic Progressive Cerebellar Ataxia in a Korean Population.
Ji Sun KIM ; Soonwook KWON ; Chang Seok KI ; Jinyoung YOUN ; Jin Whan CHO
Journal of Clinical Neurology 2018;14(3):374-380
BACKGROUND AND PURPOSE: The etiologies and frequencies of cerebellar ataxias vary between countries. Our primary aim was to determine the frequency of each diagnostic group of cerebellar ataxia patients in a Korean population. METHODS: We reviewed the medical records of patients who were being followed up between November 1994 and February 2016. We divided patients with cerebellar ataxias into familial and non-familial groups and analyzed the frequency of each etiology. Finally, we categorized patients into genetic, sporadic, secondary, and suspected genetic, but undetermined ataxia. RESULTS: A total of 820 patients were included in the study, among whom 136 (16.6%) familial patients and 684 (83.4%) non-familial cases were identified. Genetic diagnoses confirmed 98/136 (72%) familial and 72/684 (11%) nonfamilial patients. The overall etiologies of progressive ataxias comprised 170 (20.7%) genetic, 516 (62.9%) sporadic, 43 (5.2%) secondary, and 91 (11.1%) undetermined ataxia. The most common cause of ataxia was multiple-system atrophy (57.3%). In the genetic group, the most common etiology was spinocerebellar ataxia (152/170, 89.4%) and the most common subtype was spinocerebellar ataxia-3.38 of 136 familial and 53 of 684 sporadic cases (91/820, 11.1%) were undetermined ataxia. CONCLUSIONS: This is the largest epidemiological study to analyze the frequencies of various cerebellar ataxias in a Korean population based on the large database of a tertiary hospital movement-disorders clinic in South Korea. These data would be helpful for clinicians in constructing diagnostic strategies and counseling for patients with cerebellar ataxias.
Ataxia
;
Atrophy
;
Cerebellar Ataxia*
;
Counseling
;
Diagnosis
;
Epidemiologic Studies
;
Friedreich Ataxia
;
Humans
;
Korea
;
Medical Records
;
Spinocerebellar Ataxias
;
Tertiary Care Centers

Result Analysis
Print
Save
E-mail